Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about neurodegeneration: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. It is a key feature of many diseases including Alzheimer's disease, Parkinson's disease, ALS, Huntington's disease, and frontotemporal dementia. Mechanisms include protein misfolding and aggregation, mitochondrial dysfunction, oxidative stress, neuroinflammation, and impaired protein clearance. Understanding the common and disease-specific pathways of neurodegeneration is critical for developing disease-modifying therapies.
| Chinese literature search | Searches and summarizes Chinese biomedical papers |
| Medical Q&A | Answers clinical and research questions in Chinese |
| Literature translation | Translates and synthesizes English PubMed papers in Chinese |
| Guideline summarization | Extracts and summarizes clinical practice guidelines |
| Research assistance | Helps with grant writing, paper drafting, and experiment design |
| Associated Genes | MAP6, PPARGC1A, RELN, HCN1, SLC16A2, IDH2, MCU, P2RY12 |
| Therapeutic Agents | angiotensin receptor blockers, levodopa, curcumin, quercetin, aducanumab, lecanemab |
| SciDEX Hypotheses | 328 hypotheses |
| KG Connections | 3520 knowledge graph edges |
| Databases | OMIMOrphanetClinicalTrialsPubMed |
Knowledge base pages for this entity
graph TD
subgraph Interactions["Interactions"]
neurodegeneration["neurodegeneration"] -->|"affects"| neurons["neurons"]
neurodegeneration["neurodegeneration"] -->|"affects"| microglia["microglia"]
neurodegeneration["neurodegeneration"] -->|"affects"| spinal_cord["spinal cord"]
neurodegeneration["neurodegeneration"] -->|"affects"| cerebellum["cerebellum"]
neurodegeneration["neurodegeneration"] -->|"involves"| lipid_metabolism["lipid metabolism"]
neurodegeneration["neurodegeneration"] -->|"involves"| complement_cascade["complement cascade"]
neurodegeneration["neurodegeneration"] -->|"affects"| astrocytes["astrocytes"]
neurodegeneration["neurodegeneration"] -->|"affects"| oligodendrocytes["oligodendrocytes"]
neurodegeneration["neurodegeneration"] -->|"affects"| substantia_nigra["substantia nigra"]
P_TAU217["P-TAU217"] -->|"correlates with"| neurodegeneration["neurodegeneration"]
microglial_dysfunction["microglial dysfunction"] -->|"drives"| neurodegeneration["neurodegeneration"]
end
subgraph Pathology["Pathology"]
aging["aging"] -->|"associated with"| neurodegeneration["neurodegeneration"]
cGAS_STING_pathway["cGAS-STING pathway"] -->|"implicated in"| neurodegeneration["neurodegeneration"]
Lead["Lead"] -->|"causes"| neurodegeneration["neurodegeneration"]
protein_aggregation["protein aggregation"] -->|"causes"| neurodegeneration["neurodegeneration"]
end
style neurodegeneration fill:#ef5350,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style neurons fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style microglia fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style spinal_cord fill:#90a4ae,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style cerebellum fill:#90a4ae,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style lipid_metabolism fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style complement_cascade fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style astrocytes fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style oligodendrocytes fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style substantia_nigra fill:#90a4ae,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style aging fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style P_TAU217 fill:#006494,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style cGAS_STING_pathway fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Lead fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style microglial_dysfunction fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style protein_aggregation fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| spinal cord | affects | brain_region | 0.90 |
| cerebellum | affects | brain_region | 0.90 |
| complement cascade | involves | pathway | 0.90 |
| substantia nigra | affects | brain_region | 0.90 |
| glutamate signaling | involves | pathway | 0.90 |
| ferroptosis | involves | pathway | 0.90 |
| striatum | affects | brain_region | 0.90 |
| NMDA receptor | involves | receptor | 0.90 |
| axon | disrupts | organelle | 0.90 |
| cGAS-STING | involves | pathway | 0.90 |
| purinergic receptor | involves | receptor | 0.90 |
| cortical microstructure | causes | phenotype | 0.90 |
| neurons | affects | cell_type | 0.90 |
| microglia | affects | cell_type | 0.90 |
| lipid metabolism | involves | pathway | 0.90 |
| astrocytes | affects | cell_type | 0.90 |
| oligodendrocytes | affects | cell_type | 0.90 |
| dopaminergic neurons | affects | cell_type | 0.90 |
| autophagy pathway | involves | pathway | 0.90 |
| unfolded protein response | involves | pathway | 0.90 |
| macrophages | affects | cell_type | 0.90 |
| blood-brain barrier | affects | brain_region | 0.90 |
| pyroptosis | involves | pathway | 0.90 |
| hippocampus | affects | brain_region | 0.90 |
| necroptosis | involves | pathway | 0.90 |
| MAPK signaling | involves | pathway | 0.90 |
| cortex | affects | brain_region | 0.90 |
| synaptic plasticity | involves | pathway | 0.90 |
| oxidative stress response | involves | pathway | 0.90 |
| mitochondrial function | involves | pathway | 0.90 |
| neural stem cells | affects | cell_type | 0.90 |
| NAD+ metabolism | involves | pathway | 0.85 |
| neurotrophin signaling | involves | pathway | 0.85 |
| diffusion MRI signals | modulates | phenotype | 0.85 |
| white matter | affects | brain_region | 0.80 |
| mitochondrial dynamics | involves | pathway | 0.80 |
| insulin signaling | involves | pathway | 0.80 |
| thalamus | affects | brain_region | 0.80 |
| hypothalamus | affects | brain_region | 0.80 |
| brainstem | affects | brain_region | 0.80 |
| glycine | disrupts | neurotransmitter | 0.80 |
| temporal lobe | affects | brain_region | 0.80 |
| endosome | disrupts | organelle | 0.80 |
| nicotinic receptor | involves | receptor | 0.80 |
| glymphatic clearance | involves | pathway | 0.80 |
| T cells | affects | cell_type | 0.80 |
| epigenetic regulation | involves | pathway | 0.80 |
| endothelial cells | affects | cell_type | 0.80 |
| apoptosis pathway | involves | pathway | 0.80 |
| CRISPR-Cas | involves | pathway | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| aging | associated_with | phenotype | 1.00 |
| P-TAU217 | correlates_with | protein | 1.00 |
| cGAS-STING pathway | implicated_in | pathway | 1.00 |
| Lead | causes | drug | 0.95 |
| microglial dysfunction | drives | phenotype | 0.95 |
| protein aggregation | causes | process | 0.95 |
| Tardbp | causes | protein | 0.95 |
| Tau aggregation | mediates | process | 0.93 |
| C9ORF72 haploinsufficiency | causes | gene | 0.90 |
| PARK2 | associated_with | gene | 0.90 |
| LC3-associated endocytosis | associated_with | biological_process | 0.90 |
| lipid metabolism dysregulation | causes | process | 0.90 |
| autophagy | prevents | process | 0.90 |
| dysregulation of mitophagy | causes | phenotype | 0.90 |
| neuroinflammation | promotes | process | 0.90 |
| APOE4 | promotes | gene | 0.90 |
| NLRP3 | promotes | protein | 0.90 |
| GSDMD | promotes | protein | 0.90 |
| neuronal inflammation | causes | process | 0.90 |
| STING | promotes | protein | 0.90 |
| STING | therapeutic_target | protein | 0.90 |
| MAPK/ERK signaling | associated_with | pathway | 0.90 |
| APOE ε2 | improves | gene | 0.90 |
| Ca2+ | leads_to | compound | 0.90 |
| TREM2 | regulates | gene | 0.90 |
| NLRP3 | activates | gene | 0.90 |
| STING | activates | gene | 0.90 |
| PTPσ | prevents | gene | 0.90 |
| OPTN | prevents | gene | 0.90 |
| glucose metabolic reprogramming | drives | process | 0.90 |
| oligodendrocyte | drives | cell_type | 0.90 |
| intracellular calcium dysregulation | causes | process | 0.90 |
| SETX mutations | causes | process | 0.90 |
| resistance exercise | protects_against | process | 0.90 |
| endolysosomal dysfunction | contributes_to | process | 0.90 |
| medial CA1 | risk_factor_for | brain_region | 0.90 |
| protein aggregation | mediates | process | 0.90 |
| neuroinflammation | contributes_to | process | 0.90 |
| neuroinflammation | drives | process | 0.90 |
| ATXN1 | causes | gene | 0.90 |
| HDAC6 | inhibits | gene | 0.90 |
| cGAS-STING pathway | promotes | pathway | 0.90 |
| STAU1 | promotes | protein | 0.90 |
| ERK | protects_against | protein | 0.90 |
| RNA | activates | gene | 0.90 |
| ALS | regulates | gene | 0.90 |
| RNA | regulates | gene | 0.90 |
| DNA | activates | gene | 0.90 |
| ALS | interacts_with | gene | 0.90 |
| DNA | interacts_with | gene | 0.90 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neuroimmunology | 2026-04-15 | 1 hypotheses Top: 0.514
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.645
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.609
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.675
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.586
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent au [PMID:35900990] | ["Di Q", "Zhao X", "Tang H", "Li X", "Xi | Autophagy | 2023 | 1 |
| Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiqui [PMID:30966861] | ["Han X", "Sun S", "Sun Y", "Song Q", "Z | Autophagy | 2020 | 1 |
| Mapping the immune landscape of PCa: From tumor microenvironment to therapeutics [PMID:41956336] | Huang S, Ou Y, Zhuang W, Huang J, Wang B | Biochim Biophys Acta Rev Cance | 2026 | 0 |
| A scalable human-zebrafish xenotransplantation model reveals gastrosome-mediated [PMID:41957412] | Villani A, Wittmann J, Wyss T, Mallona I | Commun Biol | 2026 | 0 |
| Nlrc4 Inflammasome Expression After Acute Myocardial Infarction in Rats. [PMID:40332346] | Borim PA, Gatto M, Mota GAF, Meirelles A | Int J Mol Sci | 2025 | 0 |
| Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impair [PMID:33584302] | Huang S, Liu H, Lin Y, Liu M, Li Y et al | Front Pharmacol | 2020 | 0 |
| Inflammasome and toll-like receptor signaling in human monocytes after successfu [PMID:27260481] | Asmussen A, Fink K, Busch HJ, Helbing T, | Crit Care | 2016 | 0 |
| Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is respon [PMID:24879148] | Guo W, Sun Y, Liu W, Wu X, Guo L et al. | Autophagy | 2014 | 0 |
| Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy. [PMID:20301376] | Adam MP, Bick S, Mirzaa GM, Pagon RA, Wa | 1993 | 0 |